Papers

5

Total Citations

121

H-Index

5

About

Jon Oxley is a leading urological pathologist whose research focuses on improving functional outcomes after robot-assisted radical prostatectomy (RARP) for localized prostate cancer. His major contribution is the development and clinical validation of the NeuroSAFE technique—a standardized intraoperative frozen section analysis that enables real-time detection of positive surgical margins while preserving the periprostatic neurovascular bundles. Oxley led the landmark NeuroSAFE PROOF feasibility trial (46 citations) and the subsequent phase 3 randomized controlled trial (39 citations), which demonstrated that NeuroSAFE-guided RARP significantly improves erectile function and early urinary continence recovery compared to standard surgery. His work also includes pathological analysis of lymph nodes in anterior prostatic fat (16 citations), contributing to more accurate staging. With over 100 total citations across his most-cited papers, Oxley’s research has directly influenced surgical practice by providing an evidence-based method to balance oncological safety with quality of life. His studies are essential reading for urologists, pathologists, and researchers seeking to optimize nerve-sparing techniques in robotic prostate cancer surgery.

Research Focus

Key Achievements

5
H-Index
5
Papers
121
Total Citations
24
Avg Citations/Paper
🏆 Most Cited Paper
NeuroSAFE frozen section during robot‐assisted radical prostatectomy: peri‐operative and histopathological outcomes from the NeuroSAFE PROOF feasibility randomized controlled trial
46 citations · 2020
📈 Most Prolific Year: 2022 (2 Papers)
🤝 Key Collaborators: 48
🏛 Institutions: North Bristol NHS Trust, Bristol Hospital, Southmead Hospital

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago